Skip to main content
Premium Trial:

Request an Annual Quote

Quark, Nitto Denko Collaborate on RNAi Drugs for Fibrotic Disease

Premium

Quark Pharmaceuticals announced this week that it has formed a collaboration with Japan's Nitto Denko to develop siRNA-based drugs for fibrotic diseases.

The deal, Quark said, will combine its expertise and intellectual property related to siRNA design with Nitto Denko's drug-delivery technologies.

The collaboration will have an initial budget in the "double-digit" millions of dollars, and is expected to yield an investigational new drug application by early 2012, Quark added.

Additional terms were not disclosed.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.